Barclays Lowers Estimates on Heartware Int'l (HTWR); Q1 and 10-Q Review
Tweet Send to a FriendGet Alerts HTWR Hot Sheet
Rating Summary:
7 Buy, 9 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Analyst, Matthew Taylor, said, "HTWR released solid 1Q results last week marked by operational strength in Europe, international center adds, the recent completion of ENDURANCE enrollment, and a positive FDA panel recommendation. Following the successful panel, HTWR is turning its focus to labeling and post-approval studies, and is actively involved in discussions with the FDA."
As far as the issues in HTWR's 10-Q, Taylor said there were no new material disclosures relating to warning letters, subpoenas, litigation, recalls, or gov't investigations. However, Taylor did cut FY12 loss from -3.54 to -4.53 and FY13 from -1.05 to -1.38.
For an analyst ratings summary and ratings history on Heartware Int'l click here. For more ratings news on Heartware Int'l click here.
Shares of Heartware Int'l closed at $80.99 yesterday, with a 52 week range of $53.40-$84.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
- Needham & Company Lifts Numbers on Marvell (MRVL) on Solid Results
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
BarclaysComments
Misleading Headline
5-16-12
Hi SI,
Your “Headlines” should accurately Reflect the Gist of the Content of the article.
This one certainly DOES NOT:
http://www.streetinsider.com/Analyst+Comments/Barclays+Lowers+Estimates+on+Heartware+Intl+(HTWR)%3B+Q1+and+10-Q+Review/7446733.html
Headline: “Barclays Lowers Estimates on Heartware Int'l (HTWR)…”
Should Be: “Barclays Lowers LOSS Estimates on Heartware Int'l (HTWR)…”
- - - - - -
To Reflect: “Taylor did CUT FY12 LOSS from -3.54 to -4.53 and FY13 from -1.05 to -1.38.”
Oh what a Difference that one little word makes!
Please FWD this to SI reported that did this, and tell him how important Accurate Headlines are.
Thank you.
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!


Misleading Headline
cjgaddy on May 17, 2012 10:01 AMMark as Spam | Reply to this comment
The headline for this article s/b: "“Barclays Lowers LOSS Estimates on Heartware Int'l (HTWR)…”. Without including LOSS, very misleading.